What Indaco Venture Partners does

Indaco Venture Partners SGR is the Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital, and new materials. The company focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, the USA, Canada, and Israel. Indaco Venture Partners was founded in 2018 and is headquartered in Milan, Lombardia, Italy.

Name

Indaco Venture Partners

Legal name

Indaco Venture Partners SGR S.p.A.

Website

https://www.indacosgr.com/

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Indaco Venture Partners is an asset management company that invests in the technology, electronics, medtech, and materials sectors.

Ownership category

akta.pro rank

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Management Fees: Standard VC management fee structure charged on committed capital under management across seven funds
2. Carried Interest: Performance fees on successful exits and portfolio company liquidity events

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Indaco Venture Partners SGR is an Italian venture capital asset management firm that invests in early-stage and growth-stage technology companies across deep tech, electronics, medtech, biotech-pharma, and digital sectors. It manages seven venture capital funds with combined assets under management exceeding €363 million and provides capital plus strategic oversight to its portfolio companies.

Product overview

Indaco Venture Partners SGR is Italy's largest independent venture capital asset management company managing 7 funds with over €363 million in assets under management. The firm offers a portfolio of specialized investment funds: Indaco Ventures I (€134M) for Digital, DeepTech and Medtech growth-stage companies; Indaco BIO Fund (€97M first closing) exclusively dedicated to biotech-pharma investments in Oncology, CNS, Ophthalmology, Metabolic diseases, Virology and Infectious diseases; Indaco Ventures I – Parallel Lombardia (€14.6M) co-investing in Lombardia deeptech startups; and Indaco BIO Lombardia (€18.6M) for Lombardia biotech. The firm also manages legacy funds (Atlante Ventures, Atlante Ventures Mezzogiorno, Atlante Seed, TT Venture) from previous periods. Indaco provides venture capital investment services to innovative companies in electronics, robotics, new materials, medtech, biotech-pharma, and digital sectors, primarily in Italy with selective investments in Europe, USA, Canada, and Israel.

Differentiator

Problem solved

Functional benefit

Brands

• Indaco Ventures I: Growth-stage fund focusing on digital, deep tech and medtech with €134M AUM
• Indaco BIO
• Indaco Ventures I - Parallel Lombardia
• Indaco BIO Lombardia
• TT Venture
• Atlante Seed
• Atlante Ventures

Products and services

• Indaco Venture Capital Funds (multi-fund platform) Seven venture capital funds with combined assets under management exceeding €363 million, investing in early to growth-stage technology companies; offered to institutional and corporate limited partners.

Quantifiable outcome

• 15+ successful exits including IPOs and corporate M&A transactions
• +1 more outcomes

Named customers13 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered minor and core.

• growITup-Cariplo FactoryminorStrategic or Co-development Partner · 1 January 2026Digital sector advisory partnership with growITup-Cariplo Factory for deal sourcing and portfolio support
• Università di MilanominorStrategic or Co-development Partner · 1 January 2026Academic partnership for biotech and pharma sector deal sourcing
• Biotech Venture Advisors S.r.l.coreImplementation/ SI/ Consulting Partner · 1 January 2026Advisory firm supporting Indaco Bio Fund Investment Committee with scientific background and biotech track record; Giovanni Rizzo serves as CEO of BVA
• European Innovation Council Trusted Investor NetworkcoreStrategic or Co-development Partner · 23 October 2024Selected membership in EIC Trusted Investor Network of 70+ forward-thinking investors dedicated to Europe's deeptech sector, representing over €90 billion in assets
• Regione Lombardia - Lombardia VenturecoreStrategic or Co-development Partner · 15 July 2024Fund of funds partnership with Regione Lombardia to support Lombardy-based tech companies, co-investing up to 30 June 2028 through Parallel Lombardia fund

Scale indicators6 records

Recent moves2 records

Direct peers

• P101: P101 is an Italy-based early-stage venture capital firm investing in digital and deep tech startups. It is a direct competitor to Indaco for Italian tech deals at seed and Series A stages.
• United Ventures: United Ventures is an Italian VC firm focused on digital and technology investments. It has co-invested with Indaco in D-Orbit and MainStreaming, directly competing for similar Italian growth-stage digital deals.
• Vertis SGR: Vertis is an Italian asset management company running venture capital and private equity funds. It directly competes with Indaco for institutional capital and Italian growth-stage investment opportunities.
• LVenture Group: LVenture Group is a publicly listed Italian venture capital firm operating acceleration programs and seed funds. It overlaps with Indaco's Atlante Seed legacy vehicle and competes for early-stage Italian digital startups.
• Oltre Venture: Oltre Venture is an Italian venture capital firm focused on impact and high-innovation startups. It targets similar Italian SMEs and competes for institutional capital from Italian foundations and family offices.
• Primo Ventures: Primo Ventures is an Italian venture capital firm investing in early-stage digital and tech startups. It has co-invested alongside Indaco in D-Orbit and competes for similar Italian technology deals.

Emerging players

• Sofinnova Partners: Sofinnova Partners is a European venture capital firm specializing in life sciences and biotech, with strong Italian exposure. It co-led rounds with Indaco (e.g., Alia Therapeutics) and directly competes in European biotech Series A/B.

Broad incumbents

• Kairos Partners: Kairos is an Italian asset manager with venture capital and growth equity offerings. It is a broader incumbent in the Italian capital markets space and an indirect competitor for institutional and HNW clients.
• Azimut Investments: Azimut is a major Italian independent asset manager with venture capital and private market capabilities. It has co-invested alongside Indaco in newcleo and represents a broader incumbent alternative in Italian private markets.
• CDP Venture Capital SGR: CDP Venture Capital is Italy's state-backed venture capital firm managing multiple sector funds. It is both an anchor LP of Indaco funds and a competitor through its direct co-investment activities and Italian Technology Transfer fund.

Market position

Strengths5 records

Weaknesses5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments44 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indaco Venture Partners